Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Neurocrine Biosciences, Inc. (NBIX)

« Back to company index

NBIX Chatter Timeline

Stock Ticker for NBIX

Most Active Tweeters for NBIX

UserTweets
@Estimize 4
@mediasentiment 4
@EdgarInsider 2
@Tickeron 2
@newsfilterio 2

Recent Tweets for NBIX

badideasokay @badideasokay
@popularinvestor @itsagelfert Thoughts on $NBIX earnings report?
August 4th 2021, 11:08pm
mediasentiment @mediasentiment
$NBIX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 937
August 4th 2021, 6:08pm
mediasentiment @mediasentiment
$NBIX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 936
August 4th 2021, 6:08pm
Jarvis_Alerts @Jarvis_Alerts
$NBIX [Neurocrine Biosciences]: Morgan Stanley Maintains Overweight Lowers Price Target $116 --> 110 charts: court… https://t.co/wp3VcKUCoT
August 4th 2021, 2:08pm
AlertTrade @AlertTrade
DYNAMO GAP UP $NBIX - Neurocrine Biosciences, Inc https://t.co/QtuL6kRIrr ? TradeIdeas via ? https://t.co/VS8RO1bzXJ
August 4th 2021, 2:08pm
quantisnow @quantisnow
$NBIX ? Morgan Stanley reiterated coverage on Neurocrine Biosciences with a new price target https://t.co/xy4Wf2QcPu 30s delayed.
August 4th 2021, 1:08pm
newsfilterio @newsfilterio
Neurocrine Biosciences Reports Second Quarter 2021 Financial Results $NBIX https://t.co/EeEPVvTOyj
August 4th 2021, 9:08am
newsfilterio @newsfilterio
Neurocrine Biosciences EPS misses by $0.13, beats on revenue $NBIX https://t.co/bwrmt91DrN
August 4th 2021, 8:08am
SeekingAlpha @SeekingAlpha
$NBIX - Neurocrine Biosciences, Inc. 2021 Q2 - Results - Earnings Call Presentation. https://t.co/TBmOJ40WdT #markets #business #investing
August 4th 2021, 8:08am
maxm_profit @maxm_profit
RT @SeekingAlpha: $NBIX - Neurocrine Biosciences, Inc. (NBIX) CEO Kevin Gorman on Q2 2021 Results - Earnings Call Transcript. https://t.co/…
August 4th 2021, 7:08am
SiteFocusHQ @SiteFocusHQ
$NBIX Earnings Intelligence Analysis of recent earnings identified Neurocrine Biosciences, Inc (NASDAQ: NBIX ) busi… https://t.co/YRviLrQLUZ
August 4th 2021, 5:08am
EarningsAlley @EarningsAlley
Neurocrine Biosciences, Inc. $NBIX held an earnings call on 8/3/2021. Here are the highlights:
August 4th 2021, 2:08am
SeekingAlpha @SeekingAlpha
$NBIX - Neurocrine Biosciences, Inc. (NBIX) CEO Kevin Gorman on Q2 2021 Results - Earnings Call Transcript.… https://t.co/0eSKlgcvbX
August 4th 2021, 1:08am
MarcJacksonLA @MarcJacksonLA
$NBIX Neurocrine Biosciences Reports Second Quarter 2021 Financial Results https://t.co/7DBMYOmbsc
August 4th 2021, 12:08am
Briefingcom @Briefingcom
$NBIX: Neurocrine Biosci misses by $0.15, beats on revs https://t.co/VqiB2WjDl2
August 3rd 2021, 10:08pm
Estimize @Estimize
The most accurate $NBIX estimate is from Cantor_20, beating 6 other analysts and the Wall Street Consensus - https://t.co/9I1cUlrI8a
August 3rd 2021, 8:08pm
Estimize @Estimize
$NBIX misses the Estimize EPS Consensus by 19c and beats the Estimize Revenue Consensus by $10.89M. Reports FQ2 ear… https://t.co/90S4F4Uzlv
August 3rd 2021, 8:08pm
Estimize @Estimize
$NBIX reports FQ2 earnings of 43c EPS and $288.90M Revs - https://t.co/PWhdnbhn58
August 3rd 2021, 8:08pm
mehabecapital @mehabecapital
(Earnings) Neurocrine ( $NBIX ) Actual.EPS=0.63 vs Est.EPS=0.5076, Actual.Rev=288.9M vs Est.Rev=273.14M, Last Quote… https://t.co/Lg1aaYXPcN
August 3rd 2021, 8:08pm
realmaciej @realmaciej
RT @BioStocks: $NBIX Q2 INGREZZA Net Product Sales $265M with ~ 48,900 Total Prescriptions. Phase 3 Registrational Program of Valbenazine…
August 3rd 2021, 8:08pm
EdgarInsider @EdgarInsider
A Form 8-K [Press/News Current Report] filing has been made with the SEC: $NBIX NEUROCRINE BIOSCIENCES INC https://t.co/kWQhElOLMj
August 3rd 2021, 8:08pm
otcdynamics @otcdynamics
$NBIX Neurocrine Biosciences Reports Second Quarter 2021 Financial Results https://t.co/gjDesahECF
August 3rd 2021, 8:08pm
EdgarInsider @EdgarInsider
Filing Alert, FORM 10-Q [Quarterly Report] available. $NBIX NEUROCRINE BIOSCIENCES INC https://t.co/o04Jj6Yk30
August 3rd 2021, 8:08pm
investor_feed @investor_feed
$NBIX 10-Q Neurocrine Biosciences (3 Aug, 4:03pm) ? 2021 Q2 Earnings https://t.co/CIaTZoVBf4 #NBIX #10Q… https://t.co/GSLMr70ljh
August 3rd 2021, 8:08pm
FlashAlert_me @FlashAlert_me
$NBIX [15s. delayed] filed form 10-Q on August 03, 16:03:58 https://t.co/4VGfdwT5Mg
August 3rd 2021, 8:08pm
investor_feed @investor_feed
$NBIX 8-K Neurocrine Biosciences (3 Aug, 4:02pm) ? Neurocrine Biosciences Reports Second Quarter 2021 Financia… https://t.co/NsND1IPdbo
August 3rd 2021, 8:08pm
ethanFlare @ethanFlare
$NBIX - Neurocrine Biosciences EPS misses by $0.13, beats on revenue Cap size: mid, Float 98.7%, Short Interest 4.3… https://t.co/HsOsLa14Yo
August 3rd 2021, 8:08pm
BioStocks @BioStocks
$NBIX Q2 INGREZZA Net Product Sales $265M with ~ 48,900 Total Prescriptions. Phase 3 Registrational Program of Val… https://t.co/kLc6rasjcG
August 3rd 2021, 8:08pm
MarketCurrents @MarketCurrents
$NBIX - Neurocrine Biosciences EPS misses by $0.13, beats on revenue https://t.co/cMAAYRO1cV
August 3rd 2021, 8:08pm
StockNewsBot2 @StockNewsBot2
$NBIX Neurocrine Biosciences Reports Second Quarter 2021 Financial Results https://t.co/YuF1j8aAwa
August 3rd 2021, 8:08pm
stock_titan @stock_titan
$NBIX Neurocrine Biosciences Reports Second Quarter 2021 Financial Results https://t.co/VBcohE0vii
August 3rd 2021, 8:08pm
quantisnow @quantisnow
$NBIX ? Neurocrine Biosciences Reports Second Quarter 2021 Financial Results https://t.co/8a02kVucjC 30s delayed.
August 3rd 2021, 8:08pm
StockPods @StockPods
$NBIX Earnings Call Today: 4:30 PM EST Webcast: https://t.co/Yu2QYYU2Mf Signup for the StockPods BETA now: https://t.co/Vma4E2hQ99
August 3rd 2021, 4:08pm
Estimize @Estimize
$NBIX reports after the close, Estimize Consensus +0.12 EPS and +4.82M Revs compared to WS - https://t.co/TcIAFjZ6Pn
August 3rd 2021, 3:08pm
Tickeron @Tickeron
Neurocrine Biosciences, Inc. to report earnings on August 03, 2021. Earnings per share (EPS) estimate: $0.51 $NBIX… https://t.co/LWWDMVjnDs
August 2nd 2021, 3:08pm
Tickeron @Tickeron
$NBIX's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/AZCRSglhLk
August 1st 2021, 11:08am
TradeWithAlerts @TradeWithAlerts
Large Print $NBIX Size: 102456 Price: 93.21 Time: 1600 Amount: $9,549,923.76 - Delayed - For real time prints subsc… https://t.co/ldetlTMBHT
July 30th 2021, 8:07pm
ShortAlgoTrades @ShortAlgoTrades
$NBIX Waiting for buy signal from UltraAlgo. https://t.co/sD98rXGoCZ
July 30th 2021, 11:07am
shortalgotrader @shortalgotrader
$NBIX Waiting for buy signal https://t.co/cHOF4URXXj https://t.co/twrpv3vR5Q
July 30th 2021, 11:07am
mediasentiment @mediasentiment
$NBIX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 237
July 30th 2021, 10:07am
mediasentiment @mediasentiment
$NBIX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 232
July 30th 2021, 10:07am
InsiderForms @InsiderForms
$NBIX Insider Lloyd-Smith Malcolm has Sold 16,709 Shares. Title :Chief Regulatory Officer Total Cost: $1,567,335.95… https://t.co/1gVqDoyTVC
July 29th 2021, 9:07pm
day_trading_de @day_trading_de
NBIX (NEUROCRINE BIOSCIENCES INC) ? #Insider #stock alert! ? #Sale on 2021-07-27 - $NBIX ??: Lloyd-Smith Malcolm (C… https://t.co/l5c4IoJXYw
July 29th 2021, 9:07pm
stockmarkettile @stockmarkettile
Neurocrine Biosciences $NBIX won FDA approval for its Parkinson’s drug Ogentys a few months ago. There could be si… https://t.co/JHHvUMaS8k
July 25th 2021, 6:07am
newsfilterio @newsfilterio
Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2021 Financial Results $NBIX https://t.co/YE1qiqYDkg
July 20th 2021, 12:07am
FlashAlert_me @FlashAlert_me
$NBIX [15s. delayed]: Issued Press Release on July 19, 16:01:00: Neurocrine Biosciences Announces Conference Call a… https://t.co/7uT2DOWEMW
July 19th 2021, 8:07pm
StockNewsBot2 @StockNewsBot2
$NBIX Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2021 Financial Results https://t.co/z7IpievSv8
July 19th 2021, 8:07pm
stock_titan @stock_titan
$NBIX Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2021 Financial Results https://t.co/5kvvew3muN
July 19th 2021, 8:07pm
quantisnow @quantisnow
$NBIX ? Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2021 Financial Results https://t.co/uPYQysfQXK
July 19th 2021, 8:07pm
MarcJacksonLA @MarcJacksonLA
$NBIX HC Wainwright Maintains Buy Rating On Neurocrine, $140 PT https://t.co/dbyqTCykAI
July 17th 2021, 3:07pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.